{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:09:34Z","timestamp":1785168574149,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006579","name":"Ministry of Industry and Information Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["MCD-2023-1-09"],"award-info":[{"award-number":["MCD-2023-1-09"]}],"id":[{"id":"10.13039\/501100006579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["WLKFZ202402"],"award-info":[{"award-number":["WLKFZ202402"]}],"id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273612"],"award-info":[{"award-number":["82273612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20398"],"award-info":[{"award-number":["U21A20398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpba.2025.116772","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:25:26Z","timestamp":1740482726000},"page":"116772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum metabolic signatures and MetalnFF diagnostic score for mild and moderate metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"260","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rennan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116772_bib1","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jpba.2025.116772_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jpba.2025.116772_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2025.116772_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","article-title":"Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD","volume":"18","author":"Tamaki","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jpba.2025.116772_bib5","article-title":"Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis","volume":"11","author":"Dennis","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jpba.2025.116772_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071669","article-title":"Plasma metabolomics and machine learning-driven novel diagnostic signature for non-alcoholic steatohepatitis","volume":"10","author":"Ji","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpba.2025.116772_bib7","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.7150\/thno.40249","article-title":"Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease","volume":"10","author":"Pirmoazen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jpba.2025.116772_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10060224","article-title":"Current status of metabolomic biomarker discovery: impact of study design and demographic characteristics","volume":"10","author":"Tolstikov","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2025.116772_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1017340","article-title":"Applications of machine learning in metabolomics: disease modeling and classification","volume":"13","author":"Galal","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jpba.2025.116772_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09637486.2021.1910630","article-title":"Dietary isoflavones intake is inversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension","volume":"73","author":"Wang","year":"2022","journal-title":"Int J. Food Sci. Nutr."},{"key":"10.1016\/j.jpba.2025.116772_bib11","first-page":"600","article-title":"Application of magnetic resonance imaging-proton density fat fraction in liver fat quantification","volume":"40","author":"Yang","year":"2024","journal-title":"J. Clin. Hepatol."},{"key":"10.1016\/j.jpba.2025.116772_bib12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/nqy358","article-title":"Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial","volume":"109","author":"Chen","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jpba.2025.116772_bib13","doi-asserted-by":"crossref","first-page":"340038","DOI":"10.1016\/j.aca.2022.340038","article-title":"A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma","volume":"1220","author":"Zhao","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.116772_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2025.116772_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41512-020-00074-3","article-title":"State of the art in selection of variables and functional forms in multivariable analysis-outstanding issues","volume":"4","author":"Sauerbrei","year":"2020","journal-title":"Diagn. Progn. Res."},{"key":"10.1016\/j.jpba.2025.116772_bib16","doi-asserted-by":"crossref","first-page":"849767","DOI":"10.3389\/fnut.2022.849767","article-title":"Amino acid and fatty acid metabolism disorders trigger oxidative stress and inflammatory response in excessive dietary valine-induced NAFLD of laying hens","volume":"9","author":"Jian","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jpba.2025.116772_bib17","first-page":"96","article-title":"Protein and amino acids in nonalcoholic fatty liver disease","volume":"24","author":"Trico","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.jpba.2025.116772_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12986-022-00647-7","article-title":"Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study","volume":"19","author":"Tang","year":"2022","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.jpba.2025.116772_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nu11061356","article-title":"Glycine metabolism and its alterations in obesity and metabolic diseases","volume":"11","author":"Alves","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jpba.2025.116772_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MOL.0000000000000543","article-title":"Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism","volume":"29","author":"Rom","year":"2018","journal-title":"Curr. Opin. Lipido"},{"key":"10.1016\/j.jpba.2025.116772_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12967-021-02820-7","article-title":"Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry","volume":"19","author":"Hu","year":"2021","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.jpba.2025.116772_bib22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.jpba.2025.116772_bib23","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jpba.2025.116772_bib24","article-title":"The key role of mitochondrial function in health and disease","volume":"12","author":"San-Millan","year":"2023","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.jpba.2025.116772_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jpba.2025.116772_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1159\/000366324","article-title":"The relationship between specific Fatty acids of serum lipids and serum high sensitivity C- reactive protein levels in morbidly obese women","volume":"34","author":"Kaska","year":"2014","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.jpba.2025.116772_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136900","article-title":"The role of fatty acids in non-alcoholic fatty liver disease progression: an update","volume":"22","author":"Hliwa","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jpba.2025.116772_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/apt.15606","article-title":"Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis","volume":"51","author":"Cabre","year":"2020","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.jpba.2025.116772_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jpba.2025.116772_bib30","doi-asserted-by":"crossref","first-page":"710420","DOI":"10.3389\/fphys.2021.710420","article-title":"Metabolic changes of hepatocytes in NAFLD","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jpba.2025.116772_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13148-019-0702-5","article-title":"Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome","volume":"11","author":"Sinton","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jpba.2025.116772_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ijo.2014.53","article-title":"Mapping of the circulating metabolome reveals alpha-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease","volume":"39","author":"Rodriguez-Gallego","year":"2015","journal-title":"Int J. Obes. (Lond."},{"key":"10.1016\/j.jpba.2025.116772_bib33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1021\/jf500026s","article-title":"Investigation of the presence of beta-hydroxy-beta-methylbutyric acid and alpha-hydroxyisocaproic acid in bovine whole milk and fermented dairy products by a validated liquid chromatography-mass spectrometry method","volume":"62","author":"Ehling","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jpba.2025.116772_bib34","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3748\/wjg.v23.i15.2771","article-title":"Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease","volume":"23","author":"Dong","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jpba.2025.116772_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852500113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852500113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:15Z","timestamp":1762308975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852500113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"alternative-id":["S073170852500113X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116772","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolic signatures and MetalnFF diagnostic score for mild and moderate metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116772"}}